196 related articles for article (PubMed ID: 7365262)
1. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.
Winkelstein JA; Abramovitz AS; Tomasz A
J Immunol; 1980 May; 124(5):2502-6. PubMed ID: 7365262
[No Abstract] [Full Text] [Related]
2. The fixation of C3b to pneumococcal cell wall polymers as a result of activation of the alternative complement pathway.
Hummell DS; Berninger RW; Tomasz A; Winkelstein JA
J Immunol; 1981 Oct; 127(4):1287-9. PubMed ID: 7024404
[TBL] [Abstract][Full Text] [Related]
3. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
Holzer TJ; Edwards KM; Gewurz H; Mold C
J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
[TBL] [Abstract][Full Text] [Related]
4. Activation of the alternative pathway by pneumococcal cell walls.
Winkelstein JA; Tomasz A
J Immunol; 1977 Feb; 118(2):451-4. PubMed ID: 14211
[TBL] [Abstract][Full Text] [Related]
5. Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.
Winkelstein JA; Tomasz A
J Immunol; 1978 Jan; 120(1):174-8. PubMed ID: 24071
[No Abstract] [Full Text] [Related]
6. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
Mold C; Kingzette M; Gewurz H
J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
[TBL] [Abstract][Full Text] [Related]
7. Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.
Winkelstein JA; Shin HS; Wood WB
J Immunol; 1972 Jun; 108(6):1681-9. PubMed ID: 4402312
[No Abstract] [Full Text] [Related]
8. The third component of complement: covalent attachment of a radioactive sugar to the labile binding site of C3 via the alternative pathway.
Mann J; O'Brien R; Hostetter MK; Alper CA; Rosen FS; Babior BM
J Immunol; 1981 Jun; 126(6):2370-2. PubMed ID: 6785350
[TBL] [Abstract][Full Text] [Related]
9. The biochemistry of opsonization: central role of the reactive thiolester of the third component of complement.
Hostetter MK; Krueger RA; Schmeling DJ
J Infect Dis; 1984 Nov; 150(5):653-61. PubMed ID: 6491376
[TBL] [Abstract][Full Text] [Related]
10. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.
Edwards MS; Kasper DL; Jennings HJ; Baker CJ; Nicholson-Weller A
J Immunol; 1982 Mar; 128(3):1278-83. PubMed ID: 7035562
[No Abstract] [Full Text] [Related]
11. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
[TBL] [Abstract][Full Text] [Related]
12. Activation of the complement system by the capsule of Cryptococcus neoformans.
Kozel TR
Curr Top Med Mycol; 1993; 5():1-26. PubMed ID: 8242797
[TBL] [Abstract][Full Text] [Related]
13. Complement's alternate pathway.
Ward AN
Hosp Pract; 1979 Jun; 14(6):24. PubMed ID: 447326
[No Abstract] [Full Text] [Related]
14. Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule.
Brown EJ; Joiner KA; Cole RM; Berger M
Infect Immun; 1983 Jan; 39(1):403-9. PubMed ID: 6822421
[TBL] [Abstract][Full Text] [Related]
15. The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.
Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Verhoef J
Immunology; 1979 Jul; 37(3):615-21. PubMed ID: 500119
[TBL] [Abstract][Full Text] [Related]
16. Functional discrimination by human monocytes between their C3b receptors and their recognition units for particulate activators of the alternative complement pathway.
Czop JK; Austen KF
J Immunol; 1980 Jul; 125(1):124-8. PubMed ID: 7381198
[TBL] [Abstract][Full Text] [Related]
17. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q.
Kang YS; Do Y; Lee HK; Park SH; Cheong C; Lynch RM; Loeffler JM; Steinman RM; Park CG
Cell; 2006 Apr; 125(1):47-58. PubMed ID: 16615889
[TBL] [Abstract][Full Text] [Related]
18. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
Schenkein HA; Ruddy S
J Immunol; 1981 Jan; 126(1):11-5. PubMed ID: 6905857
[No Abstract] [Full Text] [Related]
19. [Interactions between complement system and bacterial walls].
Colomb MG; Bensa JC; Chesne S; Aubert B
Bull Eur Physiopathol Respir; 1983; 19(2):131-6. PubMed ID: 6871492
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
